Professor Georgina Long named as one of world's most highly cited researchers
4 December 2018
Melanoma Institute Australia’s Co-Medical Director Professor Georgina Long has been included in the 2018 Clarivate Analytics Highly Cited Researchers List in recognition of her global leadership in melanoma research and clinical trials.
Professor Long is one of only 12 researchers from The University of Sydney to be listed in the top one percent of researchers in their field. Professor Long was named in the Clinical Medicine category for her extensive work in melanoma research and clinical trials.
‘This is an outstanding achievement and great recognition of the global impact of Professor Long’s research, particularly in clinical trials,’ said fellow MIA Co-Medical Director Professor Richard Scolyer. ‘We are exceptionally proud to have someone of Georgina’s calibre as part of our team which is changing the face of melanoma treatment around the world.’
Now in its 5th year, the Clarivate Analytics Highly Cited Researchers List names the most influential researchers impacting their chosen fields, measured by rate of citation by their peers. Other researchers on the list include one of this year’s Nobel Laureates in Physiology or Medicine, Professor James P. Allison.
The Academic Ranking of World Universities uses the Highly Cited Researchers List to calculate the Highly Cited Score, which contributes to an institutions overall rank. This year, The University of Sydney climbed 15 places to its highest rank so far, due in no small part to research output of Professor Long and the other 11 researchers.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.